High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA

Core Insights - High Tide reported record revenue of $164 million for Q4 2025, achieving a revenue run-rate exceeding $650 million and the highest Adjusted EBITDA to date [1][2] - The company remains free cash flow positive for the fiscal year, generating $12 million in fiscal 2025 [4] - High Tide solidified its position as the largest cannabis retailer in Canada with 218 locations and a 12% market share [1][3] Financial Performance - Revenue for Q4 2025 was $164 million, a 19% increase year-over-year and the fastest growth rate in nine quarters [2][3] - Adjusted EBITDA reached a record $12.4 million, up 51% year-over-year, marking the 22nd consecutive positive quarter [2][3] - The company reported a net loss of $46.7 million for Q4 2025, impacted by one-time items, but adjusted net income would have been $1.4 million [2][3] Retail Highlights - Same-store sales increased by 4.1% in fiscal 2025 and rose 5.5% year-over-year in Q4 2025 [2][3] - Canna Cabana's annualized retail sales per square foot were $1,775, consistent year-over-year [2][3] - The company opened 27 new Canna Cabana locations in 2025, achieving the higher end of its target [1][4] Market Expansion - High Tide completed the acquisition of a majority stake in Remexian Pharma GmbH, entering the German medical cannabis market [1][3] - The company is exploring partnerships in the U.K. for distributing medical cannabis products [1][3] - Canna Cabana's membership in Canada surpassed 2.5 million, growing 45% year-over-year [2][4] Operational Developments - The company anticipates opening an additional 20-30 locations in 2026, aiming to surpass 350 locations nationwide [4] - High Tide's white label cannabis product portfolio reached 32 SKUs, with plans for significant growth [4] - The company is evaluating strategic initiatives for its U.S. CBD brands in light of recent federal developments [3][4]